Daraxonrasib demonstrated unprecedented survival benefit in Phase 3 RASolute 302 trial in previously treated metastatic pancreatic cancer; ...

The company has multiple drugs in its pipeline that could generate billions in revenue.

Revolution Medicines Inc. (NASDAQ:RVMD) is one of the best stocks to buy in a rising market, according to Wall Street ...

BeOne Medicines AG ( NASDAQ:ONC ) defied analyst predictions to release its first-quarter results, which were ahead ...

BeOne Medicines (NASDAQ:ONC) reported first-quarter 2026 results that management said reflected “strong execution across the business” and prompted the company to raise its full-year revenue outlook.

Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced the closing of its concurrent ...

View BeOne Medicines Ltd. Sponsored ADR ONC stock quote prices, financial information, real-time forecasts, and company news from CNN.

View Praxis Precision Medicines, Inc. PRAX stock quote prices, financial information, real-time forecasts, and company news from CNN.

Revolution Medicines, Inc. (NASDAQ:RVMD) has featured in the 13F portfolio of Farallon Capital since the first quarter of ...

- Potent degradation of the transcription factor ERG demonstrated across three mouse models of ERG-fusion prostate cancer, correlating with substantial tumor growth inhibition - - First-in-class ...